Table 1.
Demographics and clinical outcome of patients according to Bismuth type
| Bismuth II | Bismuth III | Bismuth IV | P value | |
| Number of patients | 21 | 47 | 66 | |
| Age (yr)1 | 68.9 ± 2.4 | 67.5 ± 1.4 | 66.6 ± 1.3 | 0.66 |
| Sex (M:F) | 16:5 | 31:16 | 46:20 | 0.74 |
| Serum bilirubin (mg/dL)1 | 9.55 ± 1.66 | 14.06 ± 1.27 | 12.69 ± 0.93 | 0.10 |
| ERBD:EPTBD:IPTBD | 6:8:7 | 12:23:12 | 16:35:15 | 0.74 |
| Palliation of cholestasis | 21 (100%) | 43 (91.5%) | 7 (88%) | 0.30 |
| Patency (d)1 | 103 ± 17 | 98 ± 12 | 113 ± 15 | 0.85 |
| Patency (d)2 | 92 (32-152) | 65 (35-95) | 81 (55-107) | |
| Procedure related cholangitis | 5 (23.8%) | 12 (25.5%) | 12 (18.2%) | 0.58 |
| Procedure related pancreatitis | 0 (0%) | 2 (4.3%) | 0 (0%) | 0.15 |
| Procedure related bleeding | 1 (4.8%) | 5 (10.6%) | 6 (9.1%) | 0.79 |
| Procedure related mortality | 0 | 0 | 0 | 1.00 |
| 30-d mortality | 0 (0%) | 1 (2.1 %) | 1 (1.5%) | 1.00 |
1
Values expressed as mean ± SE.
2
Values expressed as median (range).